Ultrasonography Echotexture as a surrogate for Sialadenitis secondary to 131I Radioiodine Therapy for differentiated Thyroid Cancer: a review and metaanalysis

To systematically review and analyze the medical literature to assess ultrasonography echotexture changes in thyroid cancer patients for the detection of chronic sialadenitis caused by radioiodine therapy. Methods: Sources were retrieved from PubMed, Scopus, EMBASE and LILACS through November 2018....

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Graziele Aparecida Simões, López, Rossana Verónica Mendoza, Ozório, Gislaine Aparecida, de Freitas, Ricardo Miguel Costa, Willegaignon, Jose, Sapienza, Marcelo Tatit, Chammas, Maria Christina, Coura-Filho, George Barberio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Medicina / USP 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536890/
https://www.ncbi.nlm.nih.gov/pubmed/33084769
http://dx.doi.org/10.6061/clinics/2020/e1843
Descripción
Sumario:To systematically review and analyze the medical literature to assess ultrasonography echotexture changes in thyroid cancer patients for the detection of chronic sialadenitis caused by radioiodine therapy. Methods: Sources were retrieved from PubMed, Scopus, EMBASE and LILACS through November 2018. All studies that assessed ultrasonographic features before (131)I administration and at 12 months after (131)I administration were selected. After data extraction, statistical analysis was performed by using Stata software. Results: From a total of 435 studies, 4 studies involving 665 patients were considered eligible, and echotexture heterogeneity was found with a significant difference. Conclusions: Ultrasound echotexture may detect chronic sialadenitis secondary to salivary radioiodine therapy.

Ejemplares similares